Last $2.11 USD
Change Today -0.02 / -0.94%
Volume 33.4K
TSPT On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

G. Kirk Raab

Lead Director, Member of Audit Committee and Member of Compensation Committee, Transcept Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 5 different organizations across 8 different industries.

See Board Relationships
78$423,031

Background*

Mr. G. Kirk Raab served as the President and Chief Operating Officer of Genentech Inc. from February 1985 to 1990, and served as Genentech's President and Chief Executive Officer from January 1990 to July 1995. Mr. Raab served as an Interim Chief Executive Officer of LXR Biotechnology from April to August 1998. Mr. Raab served as an Acting Chief Executive Officer of BiPar Sciences Inc. from September 2007 to March 3, 2008. Prior to joining Genentech Inc., in 1985, Mr. ...

Read Full Background

Corporate Headquarters*

1003 West Cutting Boulevard
Point Richmond, California 94804

United States

Phone: 510-215-3500
Fax: --

Board Members Memberships*

Former Director
Former Chairman
Director
Former Chairman
Director
Former Chairman
Chairman of the Board
1995-N/A
Former Director
1996-Present
Chairman of the Board and Chairman of Compensation Committee
1998-N/A
Former Chairman of the Board
2003-2009
Former Chairman of The Board, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2003-Present
Lead Director, Member of Audit Committee and Member of Compensation Committee
2008-Present
Chairman

Education*

BA
Colgate University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options106,092
Unexercisable Options81,908
Total Number of Options188,000

Total Compensation*

Total Annual Cash Compensation$201,000
Total Calculated Compensation$423,031
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TSPT:US $2.11 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin C. Gorman Ph.D.Chief Executive Officer, President and Director
Neurocrine Biosciences Inc.
$719.7K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Yasuchika Hasegawa Chairman of the Board and Chief Executive Officer
Takeda Pharmaceutical Company Limited
--
Mihael H. Polymeropoulos M.D.Founder, Chief Executive Officer, President and Director
Vanda Pharmaceuticals, Inc.
$515.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRANSCEPT PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.